|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
6/12/2009 9:26:10 AM
PALO ALTO, Calif.--(BUSINESS WIRE)--PrognosDx Health, Inc. announced the receipt of an exclusive, worldwide license to the patent rights associated with The University of California, Los Angeles (UCLA) technology discovered by Dr. Siavash K. Kurdistani, MD, Assistant Professor in the Department of Biological Chemistry, and Dr. David B. Seligson, MD, and colleagues at UCLA. The technology, based on the predictive power of global histone modification patterns, has broad potential uses in the development of cancer prognostic assays including response predictions to therapeutics as well as research tools and reagents.
|
|
|
|
|
|
|
|
|
|
|